The enzymatic activity of TG2 is of pharmacological interest because it is believed to contribute to the pathogenesis of diseases such as celiac sprue [6], neurodegenerative disorders [7], type 2 diabetes [8], and certain cancers [9]–[11]. This evidence concerns the gene TGM2 and celiac disease.